Andrew Bulpin is head of Process Solutions at for MilliporeSigma, the $7.6 billion Life Science business of Merck KGaA, Darmstadt, Germany. In this role, he oversees strategy, product management and marketing, research and development, contract manufacturing and testing services, as well as the Process Solutions commercial teams.
Before this role, Bulpin was head of the Process Solutions Strategic Marketing & Innovation team. Prior to that, he served as Global Head of Sales for the Pharmaceutical Chemical Solutions business.
Bulpin joined the company in 2006 as vice president of the Upstream Processing business and later assumed leadership of the Services and Solutions business. Prior to joining the company, Bulpin worked at Serologicals Corporation in a number of sales and marketing roles, both in the U.S. and Europe.
Bulpin holds a doctorate in organic chemistry from the Université de Caen, France, a Master of Business Administration degree from the University of Strathclyde, Scotland and a bachelor’s degree from the University of Sussex, England. He also worked as a postdoctoral research fellow at the Australian National University, Australia.